Oramed Pharmaceuticals, Inc. Share Price OTC Bulletin Board
Equities
US68403P1049
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Sales 2024 * | 750K 59.14M | Sales 2025 * | 2M 158M | Capitalization | 91.42M 7.21B |
---|---|---|---|---|---|
Net income 2024 * | - 0 | Net income 2025 * | -14M -1.1B | EV / Sales 2024 * | 122 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 45.7 x |
P/E ratio 2024 * |
-225
x | P/E ratio 2025 * |
-6.82
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.73% |
Managers | Title | Age | Since |
---|---|---|---|
Miriam Kidron
FOU | Founder | 83 | 11/04/02 |
Nadav Kidron
CEO | Chief Executive Officer | 50 | 11/04/02 |
Joshua Hexter
COO | Chief Operating Officer | 53 | 13/04/13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nadav Kidron
CEO | Chief Executive Officer | 50 | 11/04/02 |
Miriam Kidron
FOU | Founder | 83 | 11/04/02 |
Leonard Sank
BRD | Director/Board Member | 59 | 22/10/07 |
1st Jan change | Capi. | |
---|---|---|
+40.80% | 53.67B | |
+35.79% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |